Stocks

Barron’s 2018 Roundtable Notes: Paul Wick Long Oracle Corporation, Micron Technology, Western Digital

Paul Wick

Seligman Tech. Fund Team

For all the Barron’s 2018 Roundtable articles and notes click here.

Get The Timeless Reading eBook in PDF

Get the entire 10-part series on Timeless Reading in PDF. Save it to your desktop, read it on your tablet, or email to your colleagues.

Tumisu / Pixabay

Notes:

Long

Micron Technology (MU) $43.22 ($45.80 when published).

  • The company significantly exceeded expectations. It is growing revenue by more than 50% a year. In fact, over the past couple of years, revenue has grown by more than 100%.
  • And Micron’s profit margins have expanded significantly. Operating margins are now in the high-40% area.
  • Margins are up because the cost to add new leading edge capacity has gotten so high that people aren’t adding new capacity as easily as in the past.
  • There are three main players in DRAM: Micron, Samsung Electronics [005930.Korea], and SK Hynix [000660.Korea].
  • If you think back to 20-odd years ago, the DRAM industry was all about PCs—new operating systems and new Intel processors. Now, PC DRAM is only about 20% of demand. The demand drivers are much more diverse. Mobile phones are 20%. Servers and data centers are probably 25% to 30%. Then there’s TVs and consumer electronics; it is getting really pervasive. Even automobiles have meaningful memory content.
  • The demand from cloud data centers is inelastic because people with high-margin businesses like Google or Facebook [FB] don’t really quibble about the cost of memory. It’s not like Dell Computer 25 years ago; it would have killed to save 10 cents on a DRAM module.
  • Micron is earning about $11 to $12 a share per year. The stock is about $45, which means people don’t think the good times are going to last.
  • Not sure whether the current degree of profitability is sustainable, but we aren’t going to get down to a cyclical low with the companies losing money again.
  • The balance sheet has been cleaned up. Micron generated $1.7 billion in free cash flow in the latest quarter. The annualized free cash flow is about $7.5 billion to $8 billion. The enterprise value is about $53 billion.
  • There is a little more delevering to come. They’ll probably pay down another $2 billion or so of debt and then announce a meaningful share repurchase and capital return later in 2018.

Western Digital (WDC) $86.94 ($82.69 when published). Worth $120

  • The company is half disk drive and half flash memory (acquired Sandisk)
  • Dispute with Toshiba over. Extended the terms of the joint venture out to 2029,
  • The company reiterated that it would earn more than $13 a share in the June 2018 fiscal year. The stock is around $80 a share. It is trading for six times earnings.
  • Western Digital has a lot of debt on the balance sheet, but the company generates a prodigious amount of free cash flow per year—north of $3 billion a year.
  • They have some high-cost debt, and will significantly delever the balance sheet in the next couple of years. They even have some debt that has 10% coupon rates on it that’s callable in April 2019. That will get called.
  • The stock could go to $120. It is amazing to me that Seagate trades at a premium to Western Digital, given that Seagate is pretty much a pure magnetic disk-drive company.
  • Inevitably, over time, magnetic disk drives are going away. At least with Western Digital, they have future-proofed the company to some degree by having flash memory as well as magnetic storage.

Marvell Technology Group (MRVL) $23.56 ($23.00 when published). Worth $30 to $40.

  • Chip company. Makes disk-drive controllers for both magnetic disk drives and solid state drives.
  • Had a management change a year and a half ago.
  • In just two years Marvell’s gross margin has gone from 53% to 61%. The R&D spending that had been 36% to 40% of revenue is now 30%. And the operating profit margins, which had gotten as low as single digits, are now back up in the high-20% area.
  • It has been a pretty solid turnaround. They’ve divested some unprofitable businesses and executed well.
  • Both magnetic disk drives and solid state drives are a high-margin business—maybe as high as 70% gross margins. That’s about 55% of the company’s revenues.
  • They also have a connectivity business, making Wi-Fi, Bluetooth-type products, mostly for game controllers. Microsoft Xbox is their marquee customer.
  • Then they have a networking chip business that has lost share for the past decade to Broadcom [AVGO]. It recently has been doing better but had been sinking for a long time.
  • It is buying Cavium [CAVM]. Cavium has been one of the best network processor companies in Silicon Valley. It has processors for wireless infrastructure equipment, security firewall appliances, and enhanced security of data centers.
  • Cavium has a fast-growing ARM microprocessor family called Thunder X that has gained traction at a few cloud customers.
  • The company has ethernet switch chips, and a year and a half ago, it bought QLogic, which gave it ethernet and fiber channel adapters. That will be synergistic with Marvell’s storage-related business.
  • Has $1.7 billion or $1.8 billion of cash, and is paying about $5 billion for Cavium—half cash and half stock. It ended up taking on debt, but it is manageable.
  • Marvell has excess real estate, so it can move Cavium’s employees to its campus and cut costs.
  • While Marvell’s networking business has been steadily losing share, Cavium’s networking business is world class. By putting the two companies together, you should get a significant amount of R&D savings
  • The deal should close around midyear. Earnings per share for calendar 2019 could be in the neighborhood of $2. The stock should trade for between 15 and 20 times earnings, so that puts the price of Marvel at $30 to $40 a share a year or so from now.

Oracle (ORCL) $50.98 ($48.47 when published).

  • The company is doing well in its core database business.
  • The company has a $190 billion enterprise value. Oracle is generating about $15 billion a year in free cash flow.
  • It is a beneficiary of tax reform, and will see a 30- or 40-cent increase in earnings per share from tax reform. The company could earn around $3.63 a share in calendar 2019.
  • The company has a lot of cash offshore. Share-repurchase activity could go from $10 billion a year to $13 billion-$14 billion. With the valuation modest, revenue growing by mid-single digits over time, and a weaker dollar helping, you could see a revaluation higher.
  • Oracle trades at a lower free-cash-flow multiple than IBM. And IBM is a sinking ship in comparison to Oracle.

Short

Snap (SNAP) $14.55 ($14.50 when published)

  • The stock is below the IPO [initial public offering] price, but could sink further.
  • Advertiser feedback isn’t all that encouraging. A lot of advertisers have tried using Snap and have found it a poor return on investment.
  • The demographic is limited, so potential advertisers can’t advertise high-ticket items like cars, mortgages, or real estate. Even liquor is off-limits.
  • The product is faddish. There has been lots of executive churn.
  • They’ve lost significant share from Facebook’s Instagram Stories.
  • The financials are dreadful. The company has an enterprise value of about $15 billion on projected revenues of about $1.1 billion, and they are burning $700 million to $800 million a year of cash.
  • There is a large lockup agreement expiring on March 2 [certain insiders will be able to sell shares after that], the one-year anniversary of the IPO.

Intrexon (XON) $13.70 ($13.15 when published)

  • It operates similarly to a biotech holding company; it is a rollup of struggling biotech companies and assets.
  • Intrexon has ownership stakes in other small, struggling public companies, typically via another firm run by the CEO.
  • A big chunk of revenue—the market cap is $1.7 billion, annual revenue is $200 million—comes from cattle-breeding services. This is a strange company.
  • People get excited. The CEO made an announcement a number of years ago about licensing something from the M.D. Anderson Cancer Center, and we have seen nothing ever come of it.

Article by Brian Langis